Celularity (CELU) vs Nasus Pharma (NSRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Celularity (CELU) has outperformed Nasus Pharma (NSRX) over the past year, losing 27.9% versus a loss of 47.6%. Celularity is the larger company by market cap ($47.1 million vs $42.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CELU | NSRX |
|---|---|---|
| Share price | $1.45 | $3.65 |
| Market cap | $47.05M | $42.70M |
| 1-day change | -1.36% | -3.44% |
| YTD return | +32.43% | -58.74% |
| 1-year return | -27.94% | -47.64% |
| 5-year return | -97.96% | — |
| EPS (TTM) | $-2.73 | $-1.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.55 | $9.50 |
| 52-week low | $0.56 | $1.98 |
| Distance from 52-week high | -43.14% | -61.63% |
| Average volume | 3.89M | 16.09K |
| Shares outstanding | 32.45M | 11.71M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CELU has outperformed NSRX by 19.7 percentage points over the past year.
CELU vs NSRX FAQ
Which is bigger, Celularity or Nasus Pharma?
Celularity (CELU) is larger, with a market capitalization of $47.05M compared with $42.70M for Nasus Pharma (NSRX).
Which stock has performed better over the past year, CELU or NSRX?
CELU returned -27.94% over the past 12 months, compared with -47.64% for NSRX (price return, excluding dividends). Past performance does not predict future results.
Are Celularity and Nasus Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.